The November COSMIC release (v87) is now live! We have 4 newly expert-curated genes, a new fusion pair and a significant update to a further gene. We have continued the disease focussed curation trialled in the last release and this time we have updated the expert-curated mutation data for mesothelioma, a rare and aggressive cancer.
As part of release v87 we have continued the disease curation focus trialled in the last release and this time we have focussed on updating the expert-curated mutation data for mesothelioma, a rare and malignant cancer. Full details here.
The COSMIC team have been busy writing papers, have a read of our articles in Nature Genetics, Nature Reviews Cancer and NAR to find out about the future of COSMIC.
We seek a talented and highly motivated senior web developer to work in the COSMIC team at the Sanger Institute, Cambridge, UK. You will be a key part of the large-scale redevelopment of COSMIC, find out more here.
We're thrilled to announce that COSMIC-3D, our platform for exploring the protein sequence and structural nature of COSMIC cancer mutations, has just been published in Nature Genetics.
As part of release v86 we have focused on updating the expert-curated mutation data for glioblastoma multiforme (GBM). Approximately 70 additional publications that include mutation screening data in this disease are included in the release.
The August COSMIC release (v86) has just gone live! We have 3 newly curated genes: CHD4, IRS4 and CTCF; and the newly curated fusion pair MN1-ETV6. As part of this release we have also completed a body of curation focused on Glioblastoma.
In the near future, we are redeveloping our website and would love to hear how you interact with it, finding out what works well and what doesn’t. Sign up now to have your say!
We have introduced a new way of managing the COSMIC accounts by asking you to annually revalidate your account. In this post, we provide a step by step guide of how to do this and keep your account active.
The May COSMIC release (v85) is now live. There are 3 new fully curated genes, substantial curation updates for TERT, 1 new fusion pair, and 162 whole genome screened samples from 8 new systematic screen papers. We have also added 25 new genes to the Cancer Gene Census Hallmarks of Cancer and added a new track to the main Genome Browser which displays mutation recurrence.